Atlas Trials

An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy

Clinical trial NCT04708314 · TERMINATED

Trial details

NCT number
NCT04708314
Sponsor
Rare Disease Research, LLC
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2020-10-31
Primary completion
2021-05-13
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.